2025-07-26 - Analysis Report
Okay, here's an analysis of Hims & Hers Health Inc (HIMS) based on the data you provided.

## Hims & Hers Health Inc (HIMS) Analysis

**Company Overview:** Hims & Hers Health Inc is a telehealth company that provides personalized health and wellness products and services directly to consumers.

### 1. Performance vs. S&P 500 (VOO)

*   **HIMS Cumulative Return:** 219.75%
*   **VOO Cumulative Return:** 68.25%
*   **Relative Divergence:**
    *   **Current:** 111.7
    *   **Range:** (Min: -88.4, Max: 288.9)
    *   **Relative Divergence:** 53.0

**Analysis:** HIMS has significantly outperformed the S&P 500 (VOO) over the period for which data is available. The current divergence of 111.7 indicates a substantial outperformance. The relative divergence of 53.0 suggests that while HIMS is currently outperforming, it's in the middle of its historical outperformance range, indicating potential for further gains or a correction towards the mean.

#### Alpha, Beta Analysis

| Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
| :--------- | :------ | :---- | :------ | :---- | :----- |
| 2019-2021  | -46.0%  | 51.0% | -84.0%  | -0.0 | 1.5   |
| 2020-2022  | -15.0%  | 72.1% | -17.0%  | -0.0 | 1.4   |
| 2021-2023  | -51.0%  | 72.1% | -69.0%  | -0.1 | 2.0   |
| 2022-2024  | 127.0% | 78.4% | 101.0% | -0.1 | 5.4   |
| 2023-2025  | 215.0% | 78.4% | 163.0% | -0.1 | 12.9  |

**Analysis:**
*   **CAGR:** The Compound Annual Growth Rate (CAGR) varies significantly year-to-year, with strong growth in recent periods (2022-2025) but substantial declines in earlier periods.
*   **MDD:** The Maximum Drawdown (MDD) shows a significant downside risk, indicating that HIMS can experience considerable declines from peak to trough.
*   **Alpha:** Alpha values are generally negative in the initial periods, suggesting underperformance relative to the market. However, the Alpha becomes strongly positive in the most recent periods, indicating significant outperformance.
*   **Beta:** Beta values are close to zero or slightly negative, implying that HIMS's price movements are not highly correlated with the market (S&P 500). This suggests that HIMS's performance is driven more by company-specific factors than by broader market trends.
*   **Cap(B):** Market capitalization has increased from $1.5B in 2019-2021 to $12.9B in 2023-2025, indicating substantial growth and investor confidence.

### 2. Recent Price Action

*   **Current Price:** 57.65
*   **Previous Close:** 57.32
*   **Price Change:** 0.58
*   **5-day Moving Average:** 54.12
*   **20-day Moving Average:** 50.72
*   **60-day Moving Average:** 52.57

**Analysis:** The current price is above all the moving averages, indicating a short-term uptrend. The recent price change of 0.58 suggests a continuation of this upward momentum.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 65.51 (Approaching Overbought)
*   **PPO:** 1.98
*   **Hybrid Signal:** Cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **Recent (20-day) Relative Divergence Change:** -1.3 (Negative - Short-term Decline)
*   **Expected Return (%):** -16.5%

**Analysis:**

*   **MRI:** The low-risk MRI suggests relatively stable market conditions for HIMS.
*   **RSI:** The RSI value suggests that the stock is approaching overbought conditions, which could indicate a potential pullback or consolidation.
*   **PPO:** The PPO value indicates that the short-term moving average is above the long-term moving average, further confirming the upward trend.
*   **Hybrid Signal:** Recommends buying with caution.
*   **Recent Divergence Change:** The negative change in relative divergence suggests a short-term weakening in HIMS's outperformance compared to the S&P 500.
*   **Expected Return:** -16.5% Expected Return indicating potential for market underperformance when compared to the S&P 500.

### 4. Recent News & Significant Events

*   **[2025-07-24]** Major business developments, regulatory changes, or market events.
*   **[2025-07-23]** Analyst discussions regarding recent performance and outlook.
*   **[2025-07-22]** Notable stock volatility influenced by recent news, earnings, or executive actions.
*   **[2025-07-26]** Market experts highlighting risks and opportunities, advising investors to monitor news and announcements.

**Analysis:** The news suggests that HIMS is experiencing significant activity and scrutiny. The volatility and mixed sentiment from analysts indicate a need for careful monitoring of company announcements and market developments.

### 5. Recent Earnings Analysis

| 날짜         | EPS   | 매출       |
| :----------- | :---- | :--------- |
| 2025-05-05   | 0.22  | 0.59 B$   |
| 2024-11-04   | 0.35  | 0.40 B$   |
| 2024-08-05   | 0.06  | 0.32 B$   |
| 2024-05-06   | 0.05  | 0.28 B$   |
| 2025-05-05   | 0.05  | 0.28 B$   |

**Analysis:**
*   **EPS:** The EPS (Earnings Per Share) shows variability.
*   **Revenue:** The revenue demonstrates steady growth over the past year, suggesting that the company is successfully expanding its business.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| :----------- | :-------- | :------------ |
| 2025-03-31   | \$0.59B   | 73.50%        |
| 2024-12-31   | \$0.48B   | 76.81%        |
| 2024-09-30   | \$0.40B   | 79.16%        |
| 2024-06-30   | \$0.32B   | 81.30%        |
| 2024-03-31   | \$0.28B   | 82.36%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
| :----------- | :-------- | :----- |
| 2025-03-31   | \$0.55B   | 9.01%  |
| 2024-12-31   | \$0.48B   | 5.46%  |
| 2024-09-30   | \$0.44B   | 17.18% |
| 2024-06-30   | \$0.36B   | 3.67%  |
| 2024-03-31   | \$0.34B   | 3.23%  |

**Analysis:**

*   **Revenue and Profitability:** Revenue has shown consistent growth, but the profit margin has decreased over the period. This could indicate increased operating expenses or pricing pressures.
*   **Capital and Profitability:** Equity has increased, reflecting growth in the company's net assets. ROE (Return on Equity) fluctuates, but generally, it indicates the efficiency with which the company is using its equity to generate profits.

### 7. Overall Analysis

Hims & Hers Health Inc (HIMS) has demonstrated substantial outperformance compared to the S&P 500, but recent indicators suggest potential headwinds.

**Key Takeaways:**

*   **Strong Growth:** The company has shown robust revenue growth and a high cumulative return compared to the S&P 500.
*   **Volatility:** HIMS is a volatile stock, as evidenced by the MDD and recent news.
*   **Technical Signals:** The RSI indicates the stock is approaching overbought conditions, while the negative change in relative divergence suggests short-term weakening.
*   **Financial Health:** Revenue and equity are growing, but profit margins are decreasing, which needs monitoring.
*   **Recent News:** Market volatility and analysts discussing risks and opportunities.

**Investment Recommendation:**

Given the mixed signals, a cautious approach is warranted. While HIMS has shown impressive growth and outperformance, the increasing volatility, decreasing profit margins, and the stock approaching overbought territory suggest potential risks. Monitoring upcoming company announcements, tracking financial performance (especially profit margins), and remaining aware of market conditions are crucial.
